Christina Neuner Boyle, Thomas Alexander Lutz, Christelle Le Foll. Mol Metab 2018
Times Cited: 44
Times Cited: 44
Times Cited
Times Co-cited
Similarity
Amylin: Pharmacology, Physiology, and Clinical Potential.
Debbie L Hay, Steve Chen, Thomas A Lutz, David G Parkes, Jonathan D Roth. Pharmacol Rev 2015
Debbie L Hay, Steve Chen, Thomas A Lutz, David G Parkes, Jonathan D Roth. Pharmacol Rev 2015
36
Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies.
Jonathan D Roth, Barbara L Roland, Rebecca L Cole, James L Trevaskis, Christian Weyer, Joy E Koda, Christen M Anderson, David G Parkes, Alain D Baron. Proc Natl Acad Sci U S A 2008
Jonathan D Roth, Barbara L Roland, Rebecca L Cole, James L Trevaskis, Christian Weyer, Joy E Koda, Christen M Anderson, David G Parkes, Alain D Baron. Proc Natl Acad Sci U S A 2008
22
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management.
Xavier Pi-Sunyer, Arne Astrup, Ken Fujioka, Frank Greenway, Alfredo Halpern, Michel Krempf, David C W Lau, Carel W le Roux, Rafael Violante Ortiz, Christine Bjørn Jensen,[...]. N Engl J Med 2015
Xavier Pi-Sunyer, Arne Astrup, Ken Fujioka, Frank Greenway, Alfredo Halpern, Michel Krempf, David C W Lau, Carel W le Roux, Rafael Violante Ortiz, Christine Bjørn Jensen,[...]. N Engl J Med 2015
22
Amylin modulates the mesolimbic dopamine system to control energy balance.
Elizabeth G Mietlicki-Baase, David J Reiner, Jackson J Cone, Diana R Olivos, Lauren E McGrath, Derek J Zimmer, Mitchell F Roitman, Matthew R Hayes. Neuropsychopharmacology 2015
Elizabeth G Mietlicki-Baase, David J Reiner, Jackson J Cone, Diana R Olivos, Lauren E McGrath, Derek J Zimmer, Mitchell F Roitman, Matthew R Hayes. Neuropsychopharmacology 2015
22
Amylin receptor signaling in the ventral tegmental area is physiologically relevant for the control of food intake.
Elizabeth G Mietlicki-Baase, Laura E Rupprecht, Diana R Olivos, Derek J Zimmer, Mark D Alter, R Christopher Pierce, Heath D Schmidt, Matthew R Hayes. Neuropsychopharmacology 2013
Elizabeth G Mietlicki-Baase, Laura E Rupprecht, Diana R Olivos, Derek J Zimmer, Mark D Alter, R Christopher Pierce, Heath D Schmidt, Matthew R Hayes. Neuropsychopharmacology 2013
22
Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product.
G Christopoulos, K J Perry, M Morfis, N Tilakaratne, Y Gao, N J Fraser, M J Main, S M Foord, P M Sexton. Mol Pharmacol 1999
G Christopoulos, K J Perry, M Morfis, N Tilakaratne, Y Gao, N J Fraser, M J Main, S M Foord, P M Sexton. Mol Pharmacol 1999
22
Enhanced weight loss with pramlintide/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy.
Eric Ravussin, Steven R Smith, Julie A Mitchell, Reshma Shringarpure, Kevin Shan, Holly Maier, Joy E Koda, Christian Weyer. Obesity (Silver Spring) 2009
Eric Ravussin, Steven R Smith, Julie A Mitchell, Reshma Shringarpure, Kevin Shan, Holly Maier, Joy E Koda, Christian Weyer. Obesity (Silver Spring) 2009
20
Hypothalamic Amylin Acts in Concert with Leptin to Regulate Food Intake.
Zhiying Li, Leah Kelly, Myriam Heiman, Paul Greengard, Jeffrey Michael Friedman. Cell Metab 2015
Zhiying Li, Leah Kelly, Myriam Heiman, Paul Greengard, Jeffrey Michael Friedman. Cell Metab 2015
20
In vitro autoradiographic localization of amylin binding sites in rat brain.
P M Sexton, G Paxinos, M A Kenney, P J Wookey, K Beaumont. Neuroscience 1994
P M Sexton, G Paxinos, M A Kenney, P J Wookey, K Beaumont. Neuroscience 1994
20
Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial.
Juan Pablo Frias, Michael A Nauck, Joanna Van, Mark E Kutner, Xuewei Cui, Charles Benson, Shweta Urva, Ruth E Gimeno, Zvonko Milicevic, Deborah Robins,[...]. Lancet 2018
Juan Pablo Frias, Michael A Nauck, Joanna Van, Mark E Kutner, Xuewei Cui, Charles Benson, Shweta Urva, Ruth E Gimeno, Zvonko Milicevic, Deborah Robins,[...]. Lancet 2018
20
Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight.
C M Mack, C J Soares, J K Wilson, J R Athanacio, V F Turek, J L Trevaskis, J D Roth, P A Smith, B Gedulin, C M Jodka,[...]. Int J Obes (Lond) 2010
C M Mack, C J Soares, J K Wilson, J R Athanacio, V F Turek, J L Trevaskis, J D Roth, P A Smith, B Gedulin, C M Jodka,[...]. Int J Obes (Lond) 2010
20
Amylin receptor activation in the ventral tegmental area reduces motivated ingestive behavior.
Elizabeth G Mietlicki-Baase, Lauren E McGrath, Kieran Koch-Laskowski, Joanna Krawczyk, David J Reiner, Tram Pham, Chan Tran N Nguyen, Christopher A Turner, Diana R Olivos, Mathieu E Wimmer,[...]. Neuropharmacology 2017
Elizabeth G Mietlicki-Baase, Lauren E McGrath, Kieran Koch-Laskowski, Joanna Krawczyk, David J Reiner, Tram Pham, Chan Tran N Nguyen, Christopher A Turner, Diana R Olivos, Mathieu E Wimmer,[...]. Neuropharmacology 2017
27
Amylin receptor components and the leptin receptor are co-expressed in single rat area postrema neurons.
Claudia G Liberini, Christina N Boyle, Carlo Cifani, Marco Venniro, Bruce T Hope, Thomas A Lutz. Eur J Neurosci 2016
Claudia G Liberini, Christina N Boyle, Carlo Cifani, Marco Venniro, Bruce T Hope, Thomas A Lutz. Eur J Neurosci 2016
18
The anorectic effect of a chronic peripheral infusion of amylin is abolished in area postrema/nucleus of the solitary tract (AP/NTS) lesioned rats.
T A Lutz, A Mollet, P A Rushing, T Riediger, E Scharrer. Int J Obes Relat Metab Disord 2001
T A Lutz, A Mollet, P A Rushing, T Riediger, E Scharrer. Int J Obes Relat Metab Disord 2001
18
Amylin/Calcitonin Receptor-Mediated Signaling in POMC Neurons Influences Energy Balance and Locomotor Activity in Chow-Fed Male Mice.
Bernd Coester, Christina Koester-Hegmann, Thomas A Lutz, Christelle Le Foll. Diabetes 2020
Bernd Coester, Christina Koester-Hegmann, Thomas A Lutz, Christelle Le Foll. Diabetes 2020
53
Amylin structure-function relationships and receptor pharmacology: implications for amylin mimetic drug development.
Rebekah L Bower, Debbie L Hay. Br J Pharmacol 2016
Rebekah L Bower, Debbie L Hay. Br J Pharmacol 2016
18
Once-Weekly Semaglutide in Adults with Overweight or Obesity.
John P H Wilding, Rachel L Batterham, Salvatore Calanna, Melanie Davies, Luc F Van Gaal, Ildiko Lingvay, Barbara M McGowan, Julio Rosenstock, Marie T D Tran, Thomas A Wadden,[...]. N Engl J Med 2021
John P H Wilding, Rachel L Batterham, Salvatore Calanna, Melanie Davies, Luc F Van Gaal, Ildiko Lingvay, Barbara M McGowan, Julio Rosenstock, Marie T D Tran, Thomas A Wadden,[...]. N Engl J Med 2021
18
Mechanisms of amylin/leptin synergy in rodent models.
Victoria F Turek, James L Trevaskis, Barry E Levin, Ambrose A Dunn-Meynell, Boman Irani, Guibao Gu, Carrie Wittmer, Peter S Griffin, Calvin Vu, David G Parkes,[...]. Endocrinology 2010
Victoria F Turek, James L Trevaskis, Barry E Levin, Ambrose A Dunn-Meynell, Boman Irani, Guibao Gu, Carrie Wittmer, Peter S Griffin, Calvin Vu, David G Parkes,[...]. Endocrinology 2010
15
Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans.
E Hartter, T Svoboda, B Ludvik, M Schuller, B Lell, E Kuenburg, M Brunnbauer, W Woloszczuk, R Prager. Diabetologia 1991
E Hartter, T Svoboda, B Ludvik, M Schuller, B Lell, E Kuenburg, M Brunnbauer, W Woloszczuk, R Prager. Diabetologia 1991
15
RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor.
L M McLatchie, N J Fraser, M J Main, A Wise, J Brown, N Thompson, R Solari, M G Lee, S M Foord. Nature 1998
L M McLatchie, N J Fraser, M J Main, A Wise, J Brown, N Thompson, R Solari, M G Lee, S M Foord. Nature 1998
15
The area postrema (AP) and the parabrachial nucleus (PBN) are important sites for salmon calcitonin (sCT) to decrease evoked phasic dopamine release in the nucleus accumbens (NAc).
Lynda Whiting, James E McCutcheon, Christina N Boyle, Mitchell F Roitman, Thomas A Lutz. Physiol Behav 2017
Lynda Whiting, James E McCutcheon, Christina N Boyle, Mitchell F Roitman, Thomas A Lutz. Physiol Behav 2017
30
Infusion of the amylin antagonist AC 187 into the area postrema increases food intake in rats.
Andrea Mollet, Simone Gilg, Thomas Riediger, Thomas A Lutz. Physiol Behav 2004
Andrea Mollet, Simone Gilg, Thomas Riediger, Thomas A Lutz. Physiol Behav 2004
15
Calcitonin Receptor Neurons in the Mouse Nucleus Tractus Solitarius Control Energy Balance via the Non-aversive Suppression of Feeding.
Wenwen Cheng, Ian Gonzalez, Warren Pan, Anthony H Tsang, Jessica Adams, Ermelinda Ndoka, Desiree Gordian, Basma Khoury, Karen Roelofs, Simon S Evers,[...]. Cell Metab 2020
Wenwen Cheng, Ian Gonzalez, Warren Pan, Anthony H Tsang, Jessica Adams, Ermelinda Ndoka, Desiree Gordian, Basma Khoury, Karen Roelofs, Simon S Evers,[...]. Cell Metab 2020
21
Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25.
Debbie L Hay, Michael L Garelja, David R Poyner, Christopher S Walker. Br J Pharmacol 2018
Debbie L Hay, Michael L Garelja, David R Poyner, Christopher S Walker. Br J Pharmacol 2018
15
Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial.
Thomas A Wadden, Timothy S Bailey, Liana K Billings, Melanie Davies, Juan P Frias, Anna Koroleva, Ildiko Lingvay, Patrick M O'Neil, Domenica M Rubino, Dorthe Skovgaard,[...]. JAMA 2021
Thomas A Wadden, Timothy S Bailey, Liana K Billings, Melanie Davies, Juan P Frias, Anna Koroleva, Ildiko Lingvay, Patrick M O'Neil, Domenica M Rubino, Dorthe Skovgaard,[...]. JAMA 2021
15
MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study.
Philip Ambery, Victoria E Parker, Michael Stumvoll, Maximilian G Posch, Tim Heise, Leona Plum-Moerschel, Lan-Feng Tsai, Darren Robertson, Meena Jain, Marcella Petrone,[...]. Lancet 2018
Philip Ambery, Victoria E Parker, Michael Stumvoll, Maximilian G Posch, Tim Heise, Leona Plum-Moerschel, Lan-Feng Tsai, Darren Robertson, Meena Jain, Marcella Petrone,[...]. Lancet 2018
13
Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity.
John Blundell, Graham Finlayson, Mads Axelsen, Anne Flint, Catherine Gibbons, Trine Kvist, Julie B Hjerpsted. Diabetes Obes Metab 2017
John Blundell, Graham Finlayson, Mads Axelsen, Anne Flint, Catherine Gibbons, Trine Kvist, Julie B Hjerpsted. Diabetes Obes Metab 2017
13
GLP-1 and weight loss: unraveling the diverse neural circuitry.
Scott E Kanoski, Matthew R Hayes, Karolina P Skibicka. Am J Physiol Regul Integr Comp Physiol 2016
Scott E Kanoski, Matthew R Hayes, Karolina P Skibicka. Am J Physiol Regul Integr Comp Physiol 2016
13
Future Pharmacotherapy for Obesity: New Anti-obesity Drugs on the Horizon.
Gitanjali Srivastava, Caroline Apovian. Curr Obes Rep 2018
Gitanjali Srivastava, Caroline Apovian. Curr Obes Rep 2018
13
Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial.
Patrick M O'Neil, Andreas L Birkenfeld, Barbara McGowan, Ofri Mosenzon, Sue D Pedersen, Sean Wharton, Charlotte Giwercman Carson, Cecilie Heerdegen Jepsen, Maria Kabisch, John P H Wilding. Lancet 2018
Patrick M O'Neil, Andreas L Birkenfeld, Barbara McGowan, Ofri Mosenzon, Sue D Pedersen, Sean Wharton, Charlotte Giwercman Carson, Cecilie Heerdegen Jepsen, Maria Kabisch, John P H Wilding. Lancet 2018
13
The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss.
Anna Secher, Jacob Jelsing, Arian F Baquero, Jacob Hecksher-Sørensen, Michael A Cowley, Louise S Dalbøge, Gitte Hansen, Kevin L Grove, Charles Pyke, Kirsten Raun,[...]. J Clin Invest 2014
Anna Secher, Jacob Jelsing, Arian F Baquero, Jacob Hecksher-Sørensen, Michael A Cowley, Louise S Dalbøge, Gitte Hansen, Kevin L Grove, Charles Pyke, Kirsten Raun,[...]. J Clin Invest 2014
13
The anorectic hormone amylin contributes to feeding-related changes of neuronal activity in key structures of the gut-brain axis.
T Riediger, D Zuend, C Becskei, T A Lutz. Am J Physiol Regul Integr Comp Physiol 2004
T Riediger, D Zuend, C Becskei, T A Lutz. Am J Physiol Regul Integr Comp Physiol 2004
13
Ghrelin.
T D Müller, R Nogueiras, M L Andermann, Z B Andrews, S D Anker, J Argente, R L Batterham, S C Benoit, C Y Bowers, F Broglio,[...]. Mol Metab 2015
T D Müller, R Nogueiras, M L Andermann, Z B Andrews, S D Anker, J Argente, R L Batterham, S C Benoit, C Y Bowers, F Broglio,[...]. Mol Metab 2015
13
Lesion of the area postrema/nucleus of the solitary tract (AP/NTS) attenuates the anorectic effects of amylin and calcitonin gene-related peptide (CGRP) in rats.
T A Lutz, M Senn, J Althaus, E Del Prete, F Ehrensperger, E Scharrer. Peptides 1998
T A Lutz, M Senn, J Althaus, E Del Prete, F Ehrensperger, E Scharrer. Peptides 1998
13
Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial.
Melanie Davies, Louise Færch, Ole K Jeppesen, Arash Pakseresht, Sue D Pedersen, Leigh Perreault, Julio Rosenstock, Iichiro Shimomura, Adie Viljoen, Thomas A Wadden,[...]. Lancet 2021
Melanie Davies, Louise Færch, Ole K Jeppesen, Arash Pakseresht, Sue D Pedersen, Leigh Perreault, Julio Rosenstock, Iichiro Shimomura, Adie Viljoen, Thomas A Wadden,[...]. Lancet 2021
13
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial.
Lone B Enebo, Kasper K Berthelsen, Martin Kankam, Michael T Lund, Domenica M Rubino, Altynai Satylganova, David C W Lau. Lancet 2021
Lone B Enebo, Kasper K Berthelsen, Martin Kankam, Michael T Lund, Domenica M Rubino, Altynai Satylganova, David C W Lau. Lancet 2021
14
Inhibition of food intake in obese subjects by peptide YY3-36.
Rachel L Batterham, Mark A Cohen, Sandra M Ellis, Carel W Le Roux, Dominic J Withers, Gary S Frost, Mohammad A Ghatei, Stephen R Bloom. N Engl J Med 2003
Rachel L Batterham, Mark A Cohen, Sandra M Ellis, Carel W Le Roux, Dominic J Withers, Gary S Frost, Mohammad A Ghatei, Stephen R Bloom. N Engl J Med 2003
11
Ghrelin is a growth-hormone-releasing acylated peptide from stomach.
M Kojima, H Hosoda, Y Date, M Nakazato, H Matsuo, K Kangawa. Nature 1999
M Kojima, H Hosoda, Y Date, M Nakazato, H Matsuo, K Kangawa. Nature 1999
11
Gut hormone PYY(3-36) physiologically inhibits food intake.
Rachel L Batterham, Michael A Cowley, Caroline J Small, Herbert Herzog, Mark A Cohen, Catherine L Dakin, Alison M Wren, Audrey E Brynes, Malcolm J Low, Mohammad A Ghatei,[...]. Nature 2002
Rachel L Batterham, Michael A Cowley, Caroline J Small, Herbert Herzog, Mark A Cohen, Catherine L Dakin, Alison M Wren, Audrey E Brynes, Malcolm J Low, Mohammad A Ghatei,[...]. Nature 2002
11
Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obese humans: a randomised controlled trial.
K Wynne, A J Park, C J Small, K Meeran, M A Ghatei, G S Frost, S R Bloom. Int J Obes (Lond) 2006
K Wynne, A J Park, C J Small, K Meeran, M A Ghatei, G S Frost, S R Bloom. Int J Obes (Lond) 2006
11
Amylin Acts in the Lateral Dorsal Tegmental Nucleus to Regulate Energy Balance Through Gamma-Aminobutyric Acid Signaling.
David J Reiner, Elizabeth G Mietlicki-Baase, Diana R Olivos, Lauren E McGrath, Derek J Zimmer, Kieran Koch-Laskowski, Joanna Krawczyk, Christopher A Turner, Emily E Noble, Joel D Hahn,[...]. Biol Psychiatry 2017
David J Reiner, Elizabeth G Mietlicki-Baase, Diana R Olivos, Lauren E McGrath, Derek J Zimmer, Kieran Koch-Laskowski, Joanna Krawczyk, Christopher A Turner, Emily E Noble, Joel D Hahn,[...]. Biol Psychiatry 2017
17
The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors.
Suzanne L Dickson, Rozita H Shirazi, Caroline Hansson, Filip Bergquist, Hans Nissbrandt, Karolina P Skibicka. J Neurosci 2012
Suzanne L Dickson, Rozita H Shirazi, Caroline Hansson, Filip Bergquist, Hans Nissbrandt, Karolina P Skibicka. J Neurosci 2012
11
Ghrelin directly targets the ventral tegmental area to increase food motivation.
K P Skibicka, C Hansson, M Alvarez-Crespo, P A Friberg, S L Dickson. Neuroscience 2011
K P Skibicka, C Hansson, M Alvarez-Crespo, P A Friberg, S L Dickson. Neuroscience 2011
11
Amylin receptor signaling in the nucleus accumbens negatively modulates μ-opioid-driven feeding.
Sarah K Baisley, Brian A Baldo. Neuropsychopharmacology 2014
Sarah K Baisley, Brian A Baldo. Neuropsychopharmacology 2014
20
Pramlintide treatment reduces 24-h caloric intake and meal sizes and improves control of eating in obese subjects: a 6-wk translational research study.
Steven R Smith, John E Blundell, Colleen Burns, Cinzia Ellero, Brock E Schroeder, Nicole C Kesty, Kim S Chen, Amy E Halseth, Cameron W Lush, Christian Weyer. Am J Physiol Endocrinol Metab 2007
Steven R Smith, John E Blundell, Colleen Burns, Cinzia Ellero, Brock E Schroeder, Nicole C Kesty, Kim S Chen, Amy E Halseth, Cameron W Lush, Christian Weyer. Am J Physiol Endocrinol Metab 2007
11
Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Frank L Greenway, Ken Fujioka, Raymond A Plodkowski, Sunder Mudaliar, Maria Guttadauria, Janelle Erickson, Dennis D Kim, Eduardo Dunayevich. Lancet 2010
Frank L Greenway, Ken Fujioka, Raymond A Plodkowski, Sunder Mudaliar, Maria Guttadauria, Janelle Erickson, Dennis D Kim, Eduardo Dunayevich. Lancet 2010
11
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
11
Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial.
Kishore M Gadde, David B Allison, Donna H Ryan, Craig A Peterson, Barbara Troupin, Michael L Schwiers, Wesley W Day. Lancet 2011
Kishore M Gadde, David B Allison, Donna H Ryan, Craig A Peterson, Barbara Troupin, Michael L Schwiers, Wesley W Day. Lancet 2011
11
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.